Substituted 6,5-hetero-bicyclic derivatives
This invention relates to compounds of the formula wherein A, B, D, E, K, T, G, R3 and R5 are defined as in the specification, and to the pharmaceutically acceptable salts of such compounds.
Pfizer Inc
C C C C C
C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional
Yuhpyng L.
Chen